Xiaomeng Wang
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Rehabilitation top 2%
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Oncology 16
- Clusterin in disease pathology 10
- Co-authors
- Chenjie Xu (6 shared papers)Chenghao Liu (9 shared papers)Hao Chang (3 shared papers)Stephen E. Moss (5 shared papers)John Greenwood (5 shared papers)Peng Chen (2 shared papers)Chui Ming Gemmy Cheung (7 shared papers)Sabu Abraham (3 shared papers)
- Journals
- International Journal of Molecular Sciences (4 papers)Cell Biochemistry and Biophysics (3 papers)Nature Communications (2 papers)Medicine (2 papers)Frontiers in Medicine (2 papers)
- Partner nations
- ChinaSingaporeUnited Kingdom
In The Last Decade
Xiaomeng Wang
116 papers receiving 3.2k citations
Xiaomeng Wang's Hit Papers
Peers
Comparison fields: 5 of 147
- Pharmaceutical Science 301
- Rehabilitation 141
- Oncology 514
- Genetics 183
- Ophthalmology 134
Countries citing papers authored by Xiaomeng Wang
This map shows the geographic impact of Xiaomeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Wang more than expected).
Fields of papers citing papers by Xiaomeng Wang
This network shows the impact of papers produced by Xiaomeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Wang. The network helps show where Xiaomeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling Hit paper breakdown → | 2013 | 413 |
| 2 | Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery Hit paper breakdown → | 2018 | 284 |
| 3 | 2012 | 147 | |
| 4 | 2021 | 105 | |
| 5 | 2020 | 105 | |
| 6 | 2017 | 91 | |
| 7 | 2015 | 83 | |
| 8 | 2017 | 75 | |
| 9 | 2018 | 70 | |
| 10 | 2021 | 64 | |
| 11 | 2019 | 63 | |
| 12 | 2020 | 57 | |
| 13 | 1997 | 55 | |
| 14 | 2022 | 54 | |
| 15 | 2019 | 53 | |
| 16 | 2019 | 53 | |
| 17 | 2016 | 52 | |
| 18 | 2018 | 49 | |
| 19 | 2021 | 45 | |
| 20 | 2015 | 44 |
About Xiaomeng Wang
Xiaomeng Wang is a scholar working on Molecular Biology, Oncology, Surgery, Ophthalmology and Pulmonary and Respiratory Medicine, having authored 127 papers that have together received 3.3k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (12 papers), Clusterin in disease pathology (10 papers), Cell Adhesion Molecules Research (5 papers), Glaucoma and retinal disorders (5 papers), Wound Healing and Treatments (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Advancements in Transdermal Drug Delivery (4 papers) and Electrospun Nanofibers in Biomedical Applications (3 papers). The work is most often cited by research in Pharmaceutical Science (301 citations), Rehabilitation (141 citations), Oncology (514 citations), Genetics (183 citations) and Ophthalmology (134 citations). Xiaomeng Wang has collaborated with scholars based in China, Singapore and United Kingdom. Frequent co-authors include Chenjie Xu, Chenghao Liu, Hao Chang, Stephen E. Moss, John Greenwood, Peng Chen, Chui Ming Gemmy Cheung, Sabu Abraham, Aung Than and Clemens Lange. Their work appears in journals such as International Journal of Molecular Sciences, Cell Biochemistry and Biophysics, Nature Communications, Medicine and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.